All In Biotech

Drug Trial Radar · NCT00066872

Topical Imiquimod Compared With Surgery in Treating Patients With Basal Cell Skin Cancer

A Randomized Controlled Trial of Excisional Surgery Versus Imiquimod 5% Cream for Nodular and Superficial Basal Cell Carcinoma

Last checked: Nov 20, 2026Latest source record: Sep 17, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 500 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

500

Planned (sponsor's estimate)

Start

Oct 2002

Primary completion

Not stated

Study completion Apr 2010

Sponsor

Lead sponsor
Queen's Medical CenterAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Aug 7, 2003

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Primary purpose
Treatment
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

RATIONALE: Biological therapies such as imiquimod use different ways to stimulate the immune system and stop cancer cells from growing. It is not yet known if topical imiquimod is more effective than surgery in treating basal cell skin cancer. PURPOSE: This randomized phase III trial is studying how well topical imiquimod works compared to surgery in treating patients with basal cell skin cancer.

Conditions

  • Non-melanomatous Skin Cancer

Interventions

  • imiquimodDrug

  • conventional surgeryProcedure

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Absence of local recurrence at 3 years after start of treatment

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Chesterfield Royal Hospital

    Chesterfield, England, United Kingdom

  • Queen's Medical Centre

    Nottingham, England, United Kingdom

  • Solihull Hospital

    Solihull, England, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.